1. Dysregulation of Aquaporin-3 and Glyceryl Glucoside Restoring Action in Hidradenitis Suppurativa in Vitro Models.
- Author
-
Del Vecchio C, Gratton R, Nait-Meddour C, Nardacchione EM, Moura R, Sommella E, Moltrasio C, Marzano AV, Ura B, Mentino D, Boniotto M, d'Adamo AP, Calamita G, Crovella S, and Tricarico PM
- Subjects
- Humans, Cell Line, Aquaporin 3 metabolism, Aquaporin 3 genetics, Hidradenitis Suppurativa metabolism, Hidradenitis Suppurativa pathology, Hidradenitis Suppurativa drug therapy, Hidradenitis Suppurativa genetics, Keratinocytes metabolism, Keratinocytes drug effects, Keratinocytes pathology, Keratinocytes cytology, Cell Proliferation drug effects, Cell Movement drug effects, Glucosides pharmacology, Glucosides therapeutic use
- Abstract
Background/aims: Aquaporin-3 (AQP3) is an aquaglyceroporin and peroxiporin that plays a crucial role in skin barrier homeostasis. Dysregulated AQP3 expression has been observed in different inflammatory skin conditions. Hidradenitis Suppurativa (HS) is an autoinflammatory keratinization disease that typically appears between 10 and 21 years of age, characterized by alteration of skin barrier homeostasis., Methods: To evaluate in vitro the role of AQP3 in the development of HS, we performed real-time PCR and Western blot to analyze gene and protein levels in human keratinocyte cell lines knock-out (KO) for NCSTN and PSENEN genes, simulating genetic-associated HS. Additionally, we investigated the impact of Glyceryl Glucoside (GG) on biological processes by performing MTT, scratch, proliferation assays and proteome studies., Results: We detected a significant decrease of the levels of AQP3 gene and protein in KO cell lines. GG effectively elevated the levels of mRNA and protein, significantly decreased the hyperproliferation rate, and enhanced cell migration in our in vitro model of genetic Hidradenitis Suppurativa. Pathway enrichment analysis further confirmed GG's role in the migration and proliferation pathways of keratinocytes., Conclusion: Our results suggest that AQP3 may act as a new novel actor in HS etio-pathogenesis, and GG could be further explored as potential treatment option for managing HS in patients., Competing Interests: The authors have no conflicts of interest to declare., (© Copyright by the Author(s). Published by Cell Physiol Biochem Press.)
- Published
- 2024
- Full Text
- View/download PDF